Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01283542 · BASELINE

Baseline characteristics

Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. · Source last updated 2019-04-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      20
    units
    Participants
groups
  1. description
    All patients will receive pasireotide LAR (long acting release) 60 mg every 28 ± 3 days for 24 weeks
    id
    BG000
    title
    Pasireotide LAR
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.72
          value
          55.65
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          9
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      White/Caucasian ancestry
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Black/African ancestry
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Asian ancestry
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          4.53
          value
          26.95
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Body mass index (BMI)
    unit Of Measure
    kg/m2
population Description
Baseline participants met eligibility requirements and received at least 1 dose of study medication
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      20
    units
    Participants
groups
  1. description
    All patients will receive pasireotide LAR (long acting release) 60 mg every 28 ± 3 days for 24 weeks
    id
    BG000
    title
    Pasireotide LAR
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.72
          value
          55.65
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          9
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      White/Caucasian ancestry
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Black/African ancestry
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Asian ancestry
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          4.53
          value
          26.95
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Body mass index (BMI)
    unit Of Measure
    kg/m2
population Description
Baseline participants met eligibility requirements and received at least 1 dose of study medication

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice